OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
HKXCY Hong Kong Exchanges and Clearing Ltd
TOMZ TOMI Environmental Solutions Inc
GDXD MicroSectors? Gold Miners -3X Inverse Leveraged ETNs
CWK Cushman & Wakefield PLC
NAUT Nautilus Biotechnology Inc
ZSANQ Zosano Pharma Corp
CHX ChampionX Corp
UTZ UTZ Brands Inc
POSAF POSaBIT Systems Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

OraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's segments consist of Diagnostics and Molecular Solutions. Diagnostics business segment primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products. The Diagnostics business includes tests for diseases including COVID-19, human immunodeficiency virus (HIV) and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Molecular Solutions business products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Closing Price
$4.36
Day's Change
0.14 (3.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.81
Day's Low
4.11
Volume
(Heavy Day)
Volume:
1,972,193

10-day average volume:
1,483,414
1,972,193

OSUR's position in the Health Care Equipment & Supplies industry

Industry PeersOSURNEOGVIVOCEMI

Summary

Company ProfileOraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's...
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety...
Go to NEOG summary
Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and...
Go to VIVO summary
Chembio Diagnostics, Inc. develops and commercializes point-of-care diagnostic tests used for the rapid detection and diagnosis of infectious diseases, including sexually transmitted disease, insect...
Go to CEMI summary
52-Week Change

VS. INDUSTRY
-62.72%
-47.99%
58.29%
-68.06%
Market Cap

VS. INDUSTRY
$305.8M
$2.4B
$1.4B
$26.8M
Beta

VS. INDUSTRY
0.1
0.6
0.3
1.7
Dividend Yield

VS. INDUSTRY
--
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
49.48x
33.39x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$242.8M
$527.2M
$343.5M
$60.6M
Profit Margin

VS. INDUSTRY
-19.25%
9.16%
12.64%
-59.52%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
0.88%
16.37%
--
Revenue Growth (TTM)

VS. INDUSTRY
22.19%
12.53%
12.33%
69.84%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.